Clinical Trials in Philadelphia

Showing 5681-5700 of 15,860 trials

Evaluate the Efficacy and Safety of TGR-1202 in Participants With Chronic Lymphocytic Leukemia Who Are Intolerant to Prior Therapy

NCT02742090

The main objective of this study is to determine the progression free survival of umbralisib in participants who were intolerant to prior BTK (Bruton Tyrosine Kinase) inhibitors (ibrutinib, ACP-196, other) or prior PI3K-delta inhibitors (idelalisib, duvelisib, other).

Chronic Lymphocytic Leukemia

TG Therapeutics, Inc.51 participantsStarted Apr 2016

Huntsville, Alabama, United States • Washington D.C., District of Columbia, United States • Fort Myers, Florida, United States +12 more locations

Active Not RecruitingPhase 3< 1 mile

Training in Exercise Activities and Motion for Growth (TEAM 4 Growth) RCT

NCT04702373

This is a Phase III randomized controlled trial of a passive ROM exercise program that will be performed in infants with HLHS and other single right ventricle anomalies following the Norwood procedure at PHN and Auxiliary Centers.

Congenital Heart Disease

Carelon Research144 participantsStarted Feb 2021

Atlanta, Georgia, United States • Indianapolis, Indiana, United States • Boston, Massachusetts, United States +7 more locations

Evaluate the Efficacy and Safety of TGR-1202 in Participants With Chronic Lymphocytic Leukemia Who Are Intolerant to Prior Therapy

Training in Exercise Activities and Motion for Growth (TEAM 4 Growth) RCT

Find Trials by Condition in Philadelphia

Selective Estrogen Receptor Modulators to Enhance the Efficacy of Viral Reactivation With Histone Deacetylase Inhibitors

Oral ONC201 in Relapsed/Refractory Multiple Myeloma

Safety and Efficacy of Piromelatine in Mild Alzheimer's Disease Patients (ReCOGNITION)

An Investigational Study of Experimental Medication BMS-986165 in Participants With Moderate to Severe Crohn's Disease

Ambispective Clinical Evaluation of Sophono™

Testing the Addition of an Anti-cancer Drug, Berzosertib (M6620, VX-970), to the Usual Treatments (Carboplatin and Gemcitabine) and to Pembrolizumab for Patients With Advanced Squamous Cell Non-small Cell Lung Cancer

Dasatinib and Osimertinib (AZD9291) in Advanced Non-Small Cell Lung Cancer With EGFR Mutations

Suicide Treatment Alternatives for Teens

Clinical Evaluation of the FilmArray® Global Fever (GF) Panel

IPG Replacement Study (PREFERENCE-H)

A Study of Vibegron in Pediatric Participants 2 Years to Less Than (<) 18 Years of Age With NDO and on CIC

A Study of Atezolizumab With or Without Bevacizumab in Combination With Cisplatin Plus Gemcitabine in Patients With Untreated, Advanced Biliary Tract Cancer

A Clinical Safety Study of AT-100 (rhSP-D) in Preterm Neonates at High Risk for Bronchopulmonary Dysplasia (BPD)

CNS Penetration, PK and PD of Preoperative CC-90010 in Progressive/Recurrent Diffuse Astrocytoma, Anaplastic Astrocytoma and Glioblastoma

Study Evaluating Single Dose Of ILV-095 In Psoriasis Subjects

A Study of Ixazomib+Daratumumab+Dexamethasone (IDd) in Relapsed and/or Refractory Multiple Myeloma (RRMM)

A Study to Evaluate Safety and Efficacy of AMB-05X Injections in Subjects With TGCT

Study of AMG 160 in Subjects With Non-Small Cell Lung Cancer